Top European venture fund-raisers in 2020-22 that remain private

The European biopharmas that raised the most venture funding since the start of 2020 — and remain private today — each brought in at least $120 million. 

Though the bear market could keep these companies private a while longer, the list likely holds some of the region’s strongest IPO contenders...